Evidence map›Paper›PMID 34532119›Full record

ArticleJournal of gastrointestinal oncology2021

Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer.

Chen Zhang, Haoran Li, Yujie Huang, Yuchen Tang, Jie Wang, Yinxiang Cheng, Yijun Wei, Dongming Zhu, Zhifei Cao, Jian Zhou

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastrointestinal oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chen ZhangDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Haoran LiDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yujie HuangDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yuchen TangDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jie WangDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yinxiang ChengDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yijun WeiDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Dongming ZhuDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhifei CaoDepartment of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Jian ZhouDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPancreatic cancer is one of the most lethal malignant tumors worldwide with poor outcomes. Previous studies have shown that

methodsThis study analyzed the mRNA information and clinical data of patients from The Cancer Genome Atlas (TCGA) and the ONCOMINE databases. The gene co-expression data regarding

resultsThe expression of

conclusionsThis report suggested that

Indexed as

functional networkspancreatic cancerTNFRSF6Btumor immunity

Identifiers

PMID34532119
PMCPMC8421915
OpenAlexW3180327253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.